Novartis bets big on gene therapy with $8.7 billion AveXis deal – Reuters
Reuters |
Novartis bets big on gene therapy with $8.7 billion AveXis deal
Reuters Narasimhan is counting on AveXis’s main drug, AVXS-101, for deadly spinal muscular atrophy (SMA), as well as the Illinois-based company’s gene therapy expertise and manufacturing capabilities, to bolster Novartis’s neuroscience business, one of the … |
THV11.com KTHV |
Novartis buying gene therapy company AveXis for $8.7 billion
THV11.com KTHV A sign of Swiss pharmaceutical giant Novartis on the top of a building at the company’s campus in Basel. FABRICE COFFRINI, AFP/Getty Images. Swiss drugmaker Novartis said Monday that it will acquire a Chicago-based gene therapy company that has been … |
|
Novartis to Buy AveXis in $8.7 Billion US Gene–Therapy Deal
Bloomberg Novartis AG agreed to acquire AveXis Inc. for $8.7 billion to expand its position in gene therapy. Switzerland-based Novartis is buying the Bannockburn, Illinois, company for $218 a share, representing a premium of 88 percent to AveXis’s closing price … |
Telegraph.co.uk |
It’s all about the (stem cell) neighborhood — ScienceDaily
Science Daily Researchers have now identified how the stem cell neighborhood, known as a niche, keeps stem cells in the gut alive. Their results provide new insights into the structure of the stem cell niche in health and after injury. Are we on the brink of a stem cell revolution? – The TelegraphTelegraph.co.uk Global Pluripotent Stem Cell Market 2018-2023 Size, Analysis …Facts of Week |
The Indian Express |
Stem cell case: Ludhiana’s CMCH held guilty of medical negligence, asked to pay kin Rs 40 lakh
The Indian Express Three years after seven-year-old Harleen Kaur died after her stem cell (bone marrow) donor backed out at the last minute before a scheduled transplant, the State Consumer Disputes Redressal Commission of Punjab held the Christian Medical College and … |
The Indian Express |
Stem cell case: Ludhiana’s CMCH held guilty of medical negligence, asked to pay kin Rs 40 lakh
The Indian Express Three years after seven-year-old Harleen Kaur died after her stem cell (bone marrow) donor backed out at the last minute before a scheduled transplant, the State Consumer Disputes Redressal Commission of Punjab held the Christian Medical College and … |